Novo Holdings turns to overlooked industry: Ready with millions for diagnostics firms

Kasim Kutay, CEO of Novo Holdings, is ready to put large sums of money into diagnostics companies, an otherwise neglected industry among venture funds. Unstable success rates and difficult business models keep the investors away.

Photo: Ritzau Scanpix/Niels Hougaard

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles